Table 2 The predicted candidate genes in rectal cancer patients.

From: Novel targets in rectal cancer by considering lncRNA–miRNA–mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial

Up-regulated

AKT1, EGFR, IGF1, MET, TGFBR2, BCL2, ACVRIB, MAPK1, MAPK9, MYC, SMAD4, MAP2K1, FZD9, FZD4, FZD6, FZD10, MAP2KR1, KRAS, MAPK4, TGFBR2, IGF1R, PI3KR1, IGFB1, IGFB2, IGFBR2, APPL1, MAPK3, AKT2, AKT3, BRAF, GRB2, GRB10, CCND1, JUN, PDGFRA, DVL1, LEF1, BIRC5, CYCS

Down-regulated

APC, MSH2,MSH6, TP53, MSH3, TCF7L2, AXIN2, CTNNB1, PTEN, FOXO3, PDCD4, TCF7L2, E2F2, TCF7, BAK1, APC2, E2F1, GSK3B, BAX, SP1, RB1, GSK3B, SP1, AP1, TCF7, FRAT2, FRAT1, ESR1, ESR2, BAK1, DDB2, E2F3, ESRRG, ACVR1B, KIT, HEYL, GADD45A, CSNK1A1, CSNK1A1L, TNFSF11, SCH3, AXIN2, ZDHHC21

Back to article page